Remove first-patient-enrolled-in-fda-approved-clinical-trial-of-cbd-based-drug-for-treatment-of-ptsd
article thumbnail

First Patient Enrolled In FDA-Approved Clinical Trial Of CBD-Based Drug For Treatment Of PTSD

Medical Marijuana Program Connection

announced that the first patient has been enrolled in. The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. Read More

article thumbnail

Special Report: Current Issues in Marijuana Regulation – Veterans Struggle to Gain Access to Medical Marijuana

Cannabis Law Report

Perhaps the most characteristic medical problem of veterans is post-traumatic stress disorder (“PTSD”). The VA estimates roughly 15% of Vietnam veterans currently suffer from PTSD, but as many as 30% have experienced PTSD at some point in their lives. of the general adult population suffers from PTSD. May 2, 2019.

Access 49
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Virpax Pharmaceuticals Recaps Milestones and Highlights Product Portfolio

Cannabis Law Report

We recently announced that we anticipate commencing our initial human trial for Epoladerm™ in the second quarter of 2022. We added VRP324 which is an intranasally delivered cannabidiol (‘CBD’) formulation for the management of epilepsy in adults and children. Mack, Chairman and CEO of Virpax.

article thumbnail

Cannabis Group Weekly Alert – November 2019 #2

Cannabis Law Report

The House Education & Labor Committee approved a bill to repeal the Higher Education Act Aid Elimination Penalty, a federal law that has stripped college financial aid from hundreds of thousands of students with convictions for cannabis or other drugs. States prepare hemp plans for submission to the USDA.

Vaping 45